... >
chemical entity >
molecular entity >
polyatomic entity >
molecule >
cyclic compound >
organic cyclic compound >
carbocyclic compound >
carbopolycyclic compound >
carbobicyclic compound >
tetralins >
2-[(2r,4as,12as)-8-[[[(3,5-dimethyl-4-isoxazolyl)amino]-oxomethyl]amino]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-n-(5,6,7,8-tetrahydronaphthalen-2-yl)acetamide
... >
chemical entity >
molecular entity >
main group molecular entity >
p-block molecular entity >
carbon group molecular entity >
organic molecular entity >
organic molecule >
organic cyclic compound >
carbocyclic compound >
carbopolycyclic compound >
carbobicyclic compound >
tetralins >
2-[(2r,4as,12as)-8-[[[(3,5-dimethyl-4-isoxazolyl)amino]-oxomethyl]amino]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-n-(5,6,7,8-tetrahydronaphthalen-2-yl)acetamide
... >
chemical entity >
molecular entity >
polyatomic entity >
molecule >
organic molecule >
organic cyclic compound >
carbocyclic compound >
carbopolycyclic compound >
carbobicyclic compound >
tetralins >
2-[(2r,4as,12as)-8-[[[(3,5-dimethyl-4-isoxazolyl)amino]-oxomethyl]amino]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-n-(5,6,7,8-tetrahydronaphthalen-2-yl)acetamide
... >
chemical entity >
molecular entity >
polyatomic entity >
molecule >
cyclic compound >
organic cyclic compound >
organic aromatic compound >
benzenoid aromatic compound >
tetralins >
2-[(2r,4as,12as)-8-[[[(3,5-dimethyl-4-isoxazolyl)amino]-oxomethyl]amino]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-n-(5,6,7,8-tetrahydronaphthalen-2-yl)acetamide
... >
chemical entity >
molecular entity >
main group molecular entity >
p-block molecular entity >
carbon group molecular entity >
organic molecular entity >
organic molecule >
organic cyclic compound >
organic aromatic compound >
benzenoid aromatic compound >
tetralins >
2-[(2r,4as,12as)-8-[[[(3,5-dimethyl-4-isoxazolyl)amino]-oxomethyl]amino]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-n-(5,6,7,8-tetrahydronaphthalen-2-yl)acetamide
... >
chemical entity >
molecular entity >
polyatomic entity >
molecule >
organic molecule >
organic cyclic compound >
organic aromatic compound >
benzenoid aromatic compound >
tetralins >
2-[(2r,4as,12as)-8-[[[(3,5-dimethyl-4-isoxazolyl)amino]-oxomethyl]amino]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-n-(5,6,7,8-tetrahydronaphthalen-2-yl)acetamide
... >
chemical entity >
molecular entity >
polyatomic entity >
molecule >
cyclic compound >
organic cyclic compound >
carbocyclic compound >
benzenoid aromatic compound >
tetralins >
2-[(2r,4as,12as)-8-[[[(3,5-dimethyl-4-isoxazolyl)amino]-oxomethyl]amino]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-n-(5,6,7,8-tetrahydronaphthalen-2-yl)acetamide
... >
chemical entity >
molecular entity >
main group molecular entity >
p-block molecular entity >
carbon group molecular entity >
organic molecular entity >
organic molecule >
organic cyclic compound >
carbocyclic compound >
benzenoid aromatic compound >
tetralins >
2-[(2r,4as,12as)-8-[[[(3,5-dimethyl-4-isoxazolyl)amino]-oxomethyl]amino]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-n-(5,6,7,8-tetrahydronaphthalen-2-yl)acetamide
... >
chemical entity >
molecular entity >
polyatomic entity >
molecule >
organic molecule >
organic cyclic compound >
carbocyclic compound >
benzenoid aromatic compound >
tetralins >
2-[(2r,4as,12as)-8-[[[(3,5-dimethyl-4-isoxazolyl)amino]-oxomethyl]amino]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-n-(5,6,7,8-tetrahydronaphthalen-2-yl)acetamide
Preferred term
2-[(2r,4as,12as)-8-[[[(3,5-dimethyl-4-isoxazolyl)amino]-oxomethyl]amino]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]-n-(5,6,7,8-tetrahydronaphthalen-2-yl)acetamide
inchi
-
InChI=1S/C32H37N5O6/c1-18-30(19(2)43-36-18)35-32(40)34-23-10-13-27-25(15-23)31(39)37(3)26-12-11-24(42-28(26)17-41-27)16-29(38)33-22-9-8-20-6-4-5-7-21(20)14-22/h8-10,13-15,24,26,28H,4-7,11-12,16-17H2,1-3H3,(H,33,38)(H2,34,35,40)/t24-,26+,28-/m1/s1
inchikey
-
PMBFMNXVRNVJKX-MAARLIENSA-N
smiles
-
CC1=C(C(=NO1)C)NC(=O)NC2=CC3=C(C=C2)OC[C@@H]4[C@H](CC[C@@H](O4)CC(=O)NC5=CC6=C(CCCC6)C=C5)N(C3=O)C
URI
http://www.irandoc.acir/onto/irandoc/CHEBI:99730